about
Mutation testing in melanoma families: INK4A, CDK4 and INK4DPancreatic Cancer GeneticsTumor-suppressor genes: cardinal factors in inherited predisposition to human cancersPancreatic adenocarcinoma: epidemiology and genetics.The genetics of hereditary melanoma and nevi. 1998 update.Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients.Inherited predisposition to pancreatic cancer.The FAMMM syndrome: epidemiology and surveillance strategies.Genetics of familial and sporadic melanoma.Epidemiology of pancreatic cancer and the role of family historyUpdate on familial pancreatic cancer.The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update.Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.Localization of a putative tumor suppressor gene by using homozygous deletions in melanomasHereditary pancreatic and hepatobiliary cancersGuidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.Risk factors for pancreatic adenocarcinoma: are we ready for screening and surveillance?Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.The CDKN2A (p16) gene and human cancer.Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.Peutz-Jeghers syndrome and screening for pancreatic cancer.BRCA germline mutations in Jewish patients with pancreatic adenocarcinomaDetecting early pancreatic cancer: problems and prospectsFeatures associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.Artificial neural networks in pancreatic disease.Familial pancreatic cancer: from genes to improved patient care.Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989.Uveal melanoma and familial atypical mole and melanoma (FAM-M) syndrome.Second primary tumors in patients with cutaneous malignant melanoma.Familial melanoma.Family history of cancer.Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ.Cancer genetics in the new era of molecular biology.Multiple primary cutaneous melanomas in patients with FAMMM syndrome and sporadic atypical mole syndrome (AMS): what's worse?[Therapy of pancreatic adenocarcinoma].The genetics of melanoma
P2860
Q24649783-4EA26200-2500-41BD-ADC6-E9424A267893Q26765235-5F7E5C28-FB5A-4A2A-9412-323E58E15CACQ30499489-FBF2F059-4F9C-43DE-A0DB-CBBB0861F246Q33677968-DC9ADE1A-6FF7-4630-A669-DB78CB16525EQ33813969-E9ECB2E5-C4D6-488D-9DB4-30987B4D41AAQ33889751-C919BE2A-3749-4FA9-A54B-65830E2522F8Q33931174-8F2DC4FA-2D14-4FA9-9E2E-2F79E0D15143Q34063273-07E1A8C0-1809-4FBA-9E91-AB13C4D83CD8Q34067607-0A9728CF-F94A-4204-AFE6-9972721ECCF6Q34155002-A7626320-F365-4CD4-A6DA-17E979263D83Q34199896-22902016-1DE0-461B-944F-F9567473847CQ34211033-EAA3D627-B454-414F-9A40-1DF8A6F73F39Q34520664-58DFEA0D-EAB6-4CB1-8DF9-B488B9CC731FQ35648205-D1CA7177-37EA-4FB0-8B9A-140281387250Q35692230-54E6F7AF-6E5B-4653-BE15-C363EF7023DFQ35790591-969F8F03-E545-4EB3-9F06-BFD6F439BD26Q35810149-6064BD00-2A9B-4009-8221-FDFE2642CA6AQ36085114-49A01212-B69A-4C10-BCDE-29D337F7CA10Q36134555-ACF251D3-B81B-4986-BB2F-8ECC8043FA76Q36437816-A0CFB2A4-4929-4702-80D3-204CB1149BACQ36599686-B0C9DE1D-E44B-4721-BFD3-C10774743E53Q36658023-74D8F311-D51C-4150-A9FC-9CDEC33FFCC6Q36854437-27C6CE4E-897A-4724-8103-92FC1D365376Q36901234-78EEEA92-A6BB-41B6-9D72-26C3989BBE73Q37004819-0E3F1F0D-C3FF-4A75-9E04-0B15E832B943Q37190559-DE46D929-6C94-4F8F-8733-6AC697706A86Q37346042-3558F13F-1CF7-4047-819D-322330DD8011Q37918870-F34D1A01-D642-48D8-8246-DBCBBA57ACD7Q39501956-7B34B09D-11E0-46CC-8A80-40034FE94D8CQ40378160-9CCEB9A6-3DAE-490E-AAC4-2A46C36B2A08Q40789055-1571EB61-B8DA-4396-A4EE-0215881B131AQ40879712-ECA8FBC5-5266-471A-89CD-35259B968932Q40925436-5E2FC1F1-8799-401D-AA64-4D8F28BA4E20Q43685524-A6A297DD-76D0-4C1F-A2A0-6F1267EF3C13Q48003443-D28978E2-6D4D-4192-92A9-88799C5F6F9AQ48619732-8091F7D5-2A84-44AF-BCA2-1207EBF90594Q52975244-F84EDBA0-1E95-43EC-863C-5D6A4330BCA9Q56437102-A48F9921-E0E0-47DA-BB24-C8F21A6794E9
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Systemic cancer and the FAMMM syndrome.
@ast
Systemic cancer and the FAMMM syndrome.
@en
type
label
Systemic cancer and the FAMMM syndrome.
@ast
Systemic cancer and the FAMMM syndrome.
@en
prefLabel
Systemic cancer and the FAMMM syndrome.
@ast
Systemic cancer and the FAMMM syndrome.
@en
P2093
P2860
P356
P1476
Systemic cancer and the FAMMM syndrome.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1990.209
P407
P577
1990-06-01T00:00:00Z